JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellis, J. L.
Right arrow Articles by Zuo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellis, J. L.
Right arrow Articles by Zuo, F.

Vol. 288, Issue 3, 1143-1150, March 1999

Development of Muscarinic Analgesics Derived from Epibatidine: Role of the M4 Receptor Subtype

James L. Ellis, Dean Harman, Javier Gonzalez, Michael L. Spera, Ronggang Liu, T. Y. Shen, Donna M. Wypij and Fangming Zuo

VCB Research Inc., Cambridge, Massachusetts (J.L.E., D.M.W., F.Z.); and Chemistry Department, University of Virginia, Charlottesville, Virginia (D.H., J.G., M.L.S., R.L., T.Y.S.)

Epibatidine, a neurotoxin isolated from the skin of Epipedobates tricolor, is an efficacious antinociceptive agent with a potency 200 times that of morphine. The toxicity of epibatidine, because of its nonspecificity for both peripheral and central nicotinic receptors, precludes its development as an analgesic. During the synthesis of epibatidine analogs we developed potent antinociceptive agents, typified by CMI-936 and CMI-1145, whose antinociception, unlike that of epibatidine, is mediated via muscarinic receptors. Subsequently, we used specific muscarinic toxins and antagonists to delineate the muscarinic receptor subtype involved in the antinociception evoked by these agents. Thus, the antinociception produced by CMI-936 and CMI-1145 is inhibited substantially by 1) intrathecal injection of the specific muscarinic M4 toxin, muscarinic toxin-3; 2) intrathecally administered pertussis toxin, which inhibits the G proteins coupled to M2 and M4 receptors; and 3) s.c. injection of the M2/M4 muscarinic antagonist himbacine. These results demonstrate that the antinociception elicited by these epibatidine analogs is mediated via muscarinic M4 receptors located in the spinal cord. Compounds that specifically target the M4 receptor therefore may be of substantial value as alternative analgesics to the opiates.

0022-3565/99/2883-1143$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
H.-M. Zhang, H.-Y. Zhou, S.-R. Chen, D. Gautam, J. Wess, and H.-L. Pan
Control of Glycinergic Input to Spinal Dorsal Horn Neurons by Distinct Muscarinic Receptor Subtypes Revealed Using Knockout Mice
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 963 - 971.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. R. Sullivan, L. Leventhal, J. Harrison, V. A. Smith, T. A. Cummons, T. B. Spangler, S.-C. Sun, P. Lu, A. J. Uveges, B. W. Strassle, et al.
Pharmacological Characterization of the Muscarinic Agonist (3R,4R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in Vitro and in Vivo Models of Chronic Pain
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1294 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
H.-M. Zhang, S.-R. Chen, and H.-L. Pan
Regulation of Glutamate Release From Primary Afferents and Interneurons in the Spinal Cord by Muscarinic Receptor Subtypes
J Neurophysiol, January 1, 2007; 97(1): 102 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H.-M. Zhang, S.-R. Chen, M. Matsui, D. Gautam, J. Wess, and H.-L. Pan
Opposing Functions of Spinal M2, M3, and M4 Receptor Subtypes in Regulation of GABAergic Inputs to Dorsal Horn Neurons Revealed by Muscarinic Receptor Knockout Mice
Mol. Pharmacol., March 1, 2006; 69(3): 1048 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-M. Zhang, D.-P. Li, S.-R. Chen, and H.-L. Pan
M2, M3, and M4 Receptor Subtypes Contribute to Muscarinic Potentiation of GABAergic Inputs to Spinal Dorsal Horn Neurons
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 697 - 704.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S.-R. Chen, J. Wess, and H.-L. Pan
Functional Activity of the M2 and M4 Receptor Subtypes in the Spinal Cord Studied with Muscarinic Acetylcholine Receptor Knockout Mice
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 765 - 770.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S.-R. Chen and H.-L. Pan
Up-Regulation of Spinal Muscarinic Receptors and Increased Antinociceptive Effect of Intrathecal Muscarine in Diabetic Rats
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 676 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
S. A. Dunbar and I. G. Karamian
Cross-tolerance between spinal neostigmine and morphine in the rat
Br. J. Anaesth., September 1, 2003; 91(3): 427 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y.-J. Kang and J. C. Eisenach
Intrathecal Clonidine Reduces Hypersensitivity After Nerve Injury by a Mechanism Involving Spinal m4 Muscarinic Receptors
Anesth. Analg., May 1, 2003; 96(5): 1403 - 1408.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. Duttaroy, J. Gomeza, J.-W. Gan, N. Siddiqui, A. S. Basile, W. D. Harman, P. L. Smith, C. C. Felder, A. I. Levey, and J. Wess
Evaluation of Muscarinic Agonist-Induced Analgesia in Muscarinic Acetylcholine Receptor Knockout Mice
Mol. Pharmacol., November 1, 2002; 62(5): 1084 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Bernardini, S. K. Sauer, R. Haberberger, M. J. M. Fischer, and P. W. Reeh
Excitatory Nicotinic and Desensitizing Muscarinic (M2) Effects on C-Nociceptors in Isolated Rat Skin
J. Neurosci., May 1, 2001; 21(9): 3295 - 3302.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. U. Höglund, C. Hamilton, and L. Lindblom
Effects of Microdialyzed Oxotremorine, Carbachol, Epibatidine, and Scopolamine on Intraspinal Release of Acetylcholine in the Rat
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 100 - 104.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Gomeza, L. Zhang, E. Kostenis, C. Felder, F. Bymaster, J. Brodkin, H. Shannon, B. Xia, C.-x. Deng, and J. Wess
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice
PNAS, August 31, 1999; 96(18): 10483 - 10488.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.